A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Paclitaxel poliglumex

DRUG

Carboplatin

RADIATION

External beam radiation therapy

Trial Locations (8)

13210

SUNY Upstate Medical University, Syracuse

20010

Washington Hospital Center, Washington D.C.

63110

Washington University School of Medicine, St Louis

65211

University of Missouri, Columbia, Columbia

66045

University of Kansas, Lawrence

94143

University of California, San Francisco, San Francisco

Unknown

Rush University Medical College, Chicago

University of Minnesota, Twin Cities, Minneapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CTI BioPharma

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00352690 - A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter